Dashboard
Manage Tickers

CALXCALIX, INC

NYSE calix.com


$ 27.70 $ -0.02 (-0.07 %)    

Thursday, 25-Apr-2024 16:16:04 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 28.23
$ 27.22
$ 0.00 x 0
$ 0.00 x 0
$ 27.22 - $ 28.28
$ 26.76 - $ 53.90
1,309,784
na
1.92B
$ 1.35
$ 96.97
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-23-2024 03-30-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 10-24-2023 09-30-2023 10-Q
4 07-24-2023 07-01-2023 10-Q
5 04-24-2023 04-01-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-25-2022 10-01-2022 10-Q
8 07-26-2022 07-02-2022 10-Q
9 04-26-2022 04-02-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 10-26-2021 10-02-2021 10-Q
12 07-27-2021 07-03-2021 10-Q
13 04-27-2021 04-03-2021 10-Q
14 02-22-2021 12-31-2020 10-K
15 10-20-2020 09-26-2020 10-Q
16 07-21-2020 06-27-2020 10-Q
17 04-30-2020 03-28-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-25-2019 09-28-2019 10-Q
20 07-25-2019 06-29-2019 10-Q
21 05-01-2019 03-30-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-05-2018 09-29-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-10-2017 07-01-2017 10-Q
29 05-10-2017 04-01-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-02-2016 09-24-2016 10-Q
32 08-03-2016 06-25-2016 10-Q
33 05-04-2016 03-26-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 10-30-2015 09-26-2015 10-Q
36 07-29-2015 06-27-2015 10-Q
37 05-04-2015 03-28-2015 10-Q
38 03-04-2015 12-31-2014 10-K
39 10-30-2014 09-27-2014 10-Q
40 07-31-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jefferies-downgrades-calix-to-hold-lowers-price-target-to-30
Jefferies Downgrades Calix to Hold, Lowers...
04/25/2024 12:34:05

Jefferies analyst George Notter downgrades Calix (NYSE:CALX) from Buy to Hold and lowers the price target from $48 to $30.

9-analysts-have-this-to-say-about-calix
9 Analysts Have This To Say About Calix
04/24/2024 18:00:58

craig-hallum-maintains-buy-on-calix-lowers-price-target-to-41
Craig-Hallum Maintains Buy on Calix, Lower...
04/24/2024 17:36:04

Craig-Hallum analyst Christian Schwab maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $48 to $41.

these-analysts-slash-their-forecasts-on-calix-after-q1-results
These Analysts Slash Their Forecasts On Ca...
04/24/2024 12:08:44

roth-mkm-maintains-buy-on-calix-lowers-price-target-to-43
Roth MKM Maintains Buy on Calix, Lowers Pr...
04/24/2024 12:01:28

Roth MKM analyst Scott Searle maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $50 to $43.

needham-maintains-buy-on-calix-lowers-price-target-to-45
Needham Maintains Buy on Calix, Lowers Pri...
04/24/2024 09:32:14

Needham analyst Ryan Koontz maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $50 to $45.

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

12-information-technology-stocks-moving-in-tuesdays-pre-market-session
12 Information Technology Stocks Moving In...
04/23/2024 12:06:21

why-hibbett-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Hibbett Shares Are Trading Higher By 1...
04/23/2024 12:00:50

rosenblatt-maintains-buy-on-calix-lowers-price-target-to-35
Rosenblatt Maintains Buy on Calix, Lowers ...
04/23/2024 11:52:24

Rosenblatt analyst Mike Genovese maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $45 to $35.

why-is-telecommunications-company-calix-stock-taking-a-hit-today
Why Is Telecommunications Company Calix St...
04/23/2024 10:19:17

Explore Calix Inc's Q1 FY24 performance: a 9.5% sales decline, yet with a gross margin increase of 300 basis points to 54.2...

needham-reiterates-buy-on-calix-maintains-50-price-target
Needham Reiterates Buy on Calix, Maintains...
04/23/2024 09:58:07

Needham analyst Ryan Koontz reiterates Calix (NYSE:CALX) with a Buy and maintains $50 price target.

calix-reports-mixed-results-joins-cadence-design-systems-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Calix Reports Mixed Results, Joins Cadence...
04/23/2024 09:44:54

12-information-technology-stocks-moving-in-mondays-after-market-session
12 Information Technology Stocks Moving In...
04/22/2024 20:31:00

calix-sees-q2-adj-eps-003009-vs-024-est-revenue-1970m2030m-vs-23276m-est
Calix Sees Q2 Adj. EPS $0.03–$0.09 vs $0.2...
04/22/2024 20:24:33

calix-q1-2024-adj-eps-021-beats-020-estimate-sales-226310m-miss-228139m-estimate
Calix Q1 2024 Adj EPS $0.21 Beats $0.20 Es...
04/22/2024 20:23:06

Calix (NYSE:CALX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.20 by 5 percen...

roth-mkm-maintains-buy-on-calix-maintains-50-price-target
Roth MKM Maintains Buy on Calix, Maintains...
04/22/2024 13:22:06

Roth MKM analyst Scott Searle maintains Calix (NYSE:CALX) with a Buy and maintains $50 price target.

earnings-scheduled-for-april-22-2024
Earnings Scheduled For April 22, 2024
04/22/2024 13:07:33

Companies Reporting Before The Bell • MainStreet Bancshares (NASDAQ:MNSB) is projected to report quarterly earnings at $0.52 p...

needham-reiterates-buy-on-calix-maintains-50-price-target
Needham Reiterates Buy on Calix, Maintains...
04/17/2024 11:23:14

Needham analyst Ryan Koontz reiterates Calix (NYSE:CALX) with a Buy and maintains $50 price target.

nasdaq-turns-higher-caleres-posts-upbeat-q4-results
Nasdaq Turns Higher; Caleres Posts Upbeat ...
03/19/2024 19:02:35

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION